Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2025-09-12

EMA Authorised: Velsipity (Etrasimod arginine) — Pfizer Europe MA EEIG

View source ↗

Summary

The European Medicines Agency authorised Velsipity (etrasimod arginine) by Pfizer Europe MA EEIG for the treatment of ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VELSIPITY (ETRASIMOD)

Snippet

Status: Authorised. Therapeutic area: Colitis, Ulcerative. MAH: Pfizer Europe MA EEIG. Decision date: 11/09/2025